In 2021, a wave of non-healthcare specific investors rushed into the market, tailgating COVID-19 whilst heralding healthtech's potential. \r\nBut no sooner than the wave crested, its undertow pulled the rug out from under healthtech, leaving an industry that had previously scaled in a modest manner for decades in an oddly precarious place. \r\nFunding became cagey. Results seemed to dry up. Coffers certainly did.\r\nThere's a reason waves are often described as crashing on the shore. Healthtech has had its big moment in the spotlight. Many investors' takeaway was that this definitely wasn't an industry to make a quick buck in. And perhaps that this was an industry where there were no bucks to be made at all in Europe.\r\nHas the great VC healthtech experiment been a failure? Will VCs ever see returns? Hear both sides of the story in this discussion, and see if either viewpoint is on your wavelength.